Skip to content
Screener

Integra LifeSciences IART Q2 2026 earnings

Reported July 29, 2026 · Before market open

Revenue$418.8MBeat by $1.2M
Adjusted EPS$0.56Beat by $0.08
Revenue estimate$417.5M
EPS estimate$0.48
“At the same time, we are seeing the benefits of a more aligned commercial organization while we continue to reduce our balance sheet leverage. Supported by our broad portfolio, attractive markets, and focused leadership team, we are strengthening our operating foundation and enhancing our ability to deliver sustainable long-term shareholder value.”
Stuart Essig

Next report

Oct 29, 2026 (in a month)
Revenue estimate$416.3M
EPS estimate$0.56

Financials

Q2 2026

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$1.25B+8.3%
Enterprise value$3B+5.6%
P/S0.8×0.0×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%—

Returns & leverage

See full
Return on equity-0.7%—
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Segments

By geography

See full
Asia Pacific$48.7M+2.0%
Europe$42.6M-0.1%
Rest of World$20.4M+7.5%

By segment

See full
Specialty Surgery$309.3M+1.7%
Tissue Reconstruction$109.5M-1.9%

By product

See full
Neurosurgery$213.3M+2.0%
Private Label$28.2M+4.8%

FAQ

When did Integra LifeSciences report Q2 2026 earnings?
Integra LifeSciences (IART) reported Q2 2026 earnings on July 29, 2026 before market open.
What were Integra LifeSciences's Q2 2026 revenue and EPS?
Integra LifeSciences reported revenue of $418.8M and adjusted eps of $0.56 for Q2 2026.
Did Integra LifeSciences beat estimates in Q2 2026?
Revenue beat the consensus estimate of $417.5M by $1.2M. EPS beat the consensus estimate of $0.48 by $0.08.
How did Integra LifeSciences's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.8% from $415.6M a year earlier.
Where can I find Integra LifeSciences's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000917520-26-000055) and the 10-Q periodic report (0000917520-26-000058) directly on SEC EDGAR. The filing index links above go to sec.gov.